|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2800 USD | +14.29% |
|
+16.67% | -48.15% |
| 16/06 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 15/05 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Guided Therapeutics, Inc.
Delayed Quote OTC Markets
| 29/06/2026 | 30/06/2026 | 01/07/2026 | 02/07/2026 | |
|---|---|---|---|---|
| Last | $0.2001 | $0.2400 | $0.2450 | $0.2800 |
| Volume | 3,771 | 200 | 11,276 | 5,570 |
| Change | - | +19.94% | +2.08% | +14.29% |
| Opening | $0.2001 | $0.2005 | $0.2480 | $0.2800 |
| High | $0.2001 | $0.2400 | $0.2480 | $0.2800 |
| Low | $0.2001 | $0.2005 | $0.2100 | $0.2380 |
Performance
| 1 day | +14.29% | ||
| 1 week | +16.67% | ||
| Current month | +16.67% | ||
| 1 month | +40.00% | ||
| 3 months | +21.74% | ||
| 6 months | -41.67% | ||
| Current year | -48.15% | ||
| 1 year | +7.69% | ||
| 3 years | +31.70% | ||
| 5 years | -58.21% | ||
| 10 years | -99.99% |
Volumes
marketsDaily volume
5,570
Estimated daily volume
5,570
Avg. Volume 20 sessions
7,984
Daily volume ratio
0.7
Avg. Volume 20 sessions USD
2,235.52
Record volume 1
6,51,663
Record volume 2
5,13,070
Record volume 3
4,77,539
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
2,70,30,457
Net sales ()
7,67,000
Number of employees
3
Sales / Employee (USD)
2,55,667
Free-Float
63.48 %
Free-Float capitalization (USD)
1,71,59,663
Average Daily Capital Traded
0.01%
Indicators
Moving average 5 days
0.255
Moving average 20 days
0.1822
Moving average 50 days
0.1854
Moving average 100 days
0.2505
Price spread / (MMA5)
-8.93%
Price spread / (MMA20)
-34.93%
Price spread / (MMA50)
-33.79%
Price spread / (MMA100)
-10.54%
STIM
RSI 9 days
38.02
RSI 14 days
42.19
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +14.29% | +16.67% | +7.69% | +31.70% | 2.7Cr | |
| -0.19% | +3.04% | +23.39% | +0.56% | 19TCr | |
| -1.28% | +7.45% | -20.09% | +28.98% | 15TCr | |
| +0.29% | +1.95% | -2.73% | -16.69% | 14TCr | |
| +1.57% | +6.14% | -56.37% | -13.37% | 6.73TCr | |
| -0.38% | +4.82% | +23.64% | +5.05% | 5.46TCr | |
| -2.30% | +0.94% | -25.92% | -30.38% | 4.49TCr | |
| -1.05% | -0.03% | +8.13% | +41.94% | 3.68TCr | |
| +0.41% | -1.27% | +9.97% | +12.09% | 3.7TCr | |
| +0.62% | +12.76% | -14.30% | +1.83% | 3.17TCr | |
| Average | +1.22% | +3.94% | -4.66% | +6.17% | 7.53TCr | |
| Weighted average by Cap. | -0.27% | +4.08% | -3.16% | +3.00% |
Historical Quotes: Guided Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 0.24 |  | 0.28 |
| 1 month | 0.18 | | 0.34 |
| Current year | 0.17 | | 0.54 |
| 1 year | 0.12 | | 0.54 |
| 3 years | 0.06 | | 0.54 |
| 5 years | 0.06 | | 0.78 |
| 10 years | 0.02 | | 4,160 |
Monthly variations
Annual variations
| 2026 | -48.15% | ||
| 2025 | +260.00% | ||
| 2024 | -2.28% | ||
| 2023 | -48.83% | ||
| 2022 | -48.29% | ||
| 2021 | +93.46% | ||
| 2020 | +125.49% | ||
| 2019 | -44.58% | ||
| 2018 | -98.80% | ||
| 2017 | -95.36% | ||
| 2016 | -99.96% | ||
| 2015 | -93.48% | ||
| 2014 | -52.10% | ||
| 2013 | -29.41% | ||
| 2012 | -55.26% | ||
| 2011 | +90.00% | ||
| 2010 | -28.57% | ||
| 2009 | +460.00% | ||
| 2008 | +5.26% | ||
| 2007 | -36.67% | ||
| 2006 | +20.00% | ||
| 2005 | -50.98% | ||
| 2004 | -74.50% | ||
| 2003 | +24.22% | ||
| 2002 | -76.67% | ||
| 2001 | -6.44% | ||
| 2000 | -38.22% | ||
| 1999 | +97.93% | ||
| 1998 | -10.65% | ||
| 1997 | -3.57% |
- Stock Market
- Stocks
- GTHP Stock
- Quotes Guided Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
